EPHA4 and amyotrophic lateral sclerosis: Interestingly, antagonism of EphA4 improves long-term potentiation defects in a mouse model for Alzheimer's disease and improves outcome in animal models for amyotrophic lateral sclerosis (ALS)9 and stroke (9, –, 12).